The amendatory effect of hesperidin and thymol in allergic rhinitis: an ovalbumin-induced rat model.
Animals
Anti-Infective Agents
/ pharmacology
Antioxidants
/ pharmacology
Disease Models, Animal
Hesperidin
/ pharmacology
Immunoglobulin E
/ blood
Inflammation
/ pathology
Interleukin-13
/ blood
Interleukin-5
/ blood
Nasal Cavity
/ metabolism
Ovalbumin
/ adverse effects
Oxidants
/ metabolism
Rats, Sprague-Dawley
Rhinitis, Allergic
/ drug therapy
Thymol
/ pharmacology
Tumor Necrosis Factor-alpha
/ metabolism
Allergic rhinitis
Hesperidin
Immunoglobulin-E
Ovalbumin
Thymol
Journal
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
14
09
2018
accepted:
26
11
2018
pubmed:
30
11
2018
medline:
12
4
2019
entrez:
30
11
2018
Statut:
ppublish
Résumé
Allergic rhinitis is an immunoglobulin-E (Ig-E)-mediated response driven by type 2 helper T cells. Hesperidin and thymol are biological agents that possess antioxidant and anti-inflammatory characteristics. The purpose of this study was to investigate the effects of hesperidin and thymol in rats with ovalbumin-induced allergic rhinitis. Thirty adult Sprague-Dawley rats were randomly assigned into five groups, each containing six animals. The first group constituted the negative control group, while the remaining groups were exposed to an ovalbumin-induced model of allergic rhinitis. In the provocation stage, 4 mL/kg saline was administered to the positive control group, 10 mg/kg desloratadine to the reference group, 100 mg/kg hesperidin to the hesperidin group, and 20 mg/kg thymol to the thymol group, all by gastric lavage for 7 days. Nasal symptoms were scored on day 22. Rats were then sacrificed, and intracardiac blood specimens were collected to measure plasma total Ig-E, IL-5, IL-13, total antioxidant capacity (TAC), and total oxidant status (TOS) levels. Nasal tissues were extracted for histopathological and immunochemical examination. Nasal symptom scores were highest in the positive control group, while hesperidin and thymol ameliorated these symptoms to the same extent as desloratadine. Ig-E, IL-5, IL-13, and TOS levels increased, while TAC levels decreased significantly in the allergic rhinitis group compared to the other groups. Significant improvement in these parameters was observed in both the hesperidin and thymol groups. At histopathological and immunohistochemical examination of the nasal cavity, severe allergic inflammation and severe TNF-α expression was determined in rats from the allergic rhinitis group. Mild inflammatory changes and mild TNF-α expression were observed in all three treatment groups. Both hesperidin and thymol were effective in suppressing allergic symptoms and inflammation in the treatment of allergic rhinitis.
Identifiants
pubmed: 30488351
doi: 10.1007/s00405-018-5222-y
pii: 10.1007/s00405-018-5222-y
doi:
Substances chimiques
Anti-Infective Agents
0
Antioxidants
0
Interleukin-13
0
Interleukin-5
0
Oxidants
0
Tumor Necrosis Factor-alpha
0
Immunoglobulin E
37341-29-0
Thymol
3J50XA376E
Ovalbumin
9006-59-1
Hesperidin
E750O06Y6O
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
407-415Références
Eur Arch Otorhinolaryngol. 2017 Aug;274(8):3087-3095
pubmed: 28493194
Environ Sci Pollut Res Int. 2018 Jul;25(21):20968-20984
pubmed: 29766429
Neuroimmunomodulation. 2007;14(2):78-83
pubmed: 17713354
Food Chem. 2013 Nov 15;141(2):1104-13
pubmed: 23790892
Eur Arch Otorhinolaryngol. 2018 Jan;275(1):117-124
pubmed: 29071443
Int Immunopharmacol. 2018 Jun;59:301-309
pubmed: 29679854
Inflammation. 2012 Feb;35(1):114-21
pubmed: 21287361
Phytother Res. 2015 Mar;29(3):323-31
pubmed: 25394264
J Biochem Mol Toxicol. 2016 Jan;30(1):37-44
pubmed: 26387986
Int Immunopharmacol. 2017 Jun;47:182-189
pubmed: 28412624
Balkan Med J. 2016 Nov;33(6):620-626
pubmed: 27994914
Clin Biochem. 2004 Apr;37(4):277-85
pubmed: 15003729
Planta Med. 2005 Jan;71(1):24-7
pubmed: 15678369
Allergy. 2001;56 Suppl 67:70-4
pubmed: 11298014
Lancet. 2011 Dec 17;378(9809):2112-22
pubmed: 21783242
Lipids Health Dis. 2017 Aug 14;16(1):152
pubmed: 28806973
Arch Physiol Biochem. 2019 Dec;125(5):396-403
pubmed: 29799283
Toxicol Lett. 2009 Feb 10;184(3):204-10
pubmed: 19110045
Phytother Res. 2001 Dec;15(8):655-69
pubmed: 11746857
Clin Biochem. 2005 Dec;38(12):1103-11
pubmed: 16214125
Food Chem Toxicol. 1994 Jan;32(1):31-6
pubmed: 7510659
Cell Biochem Funct. 2017 Oct;35(7):420-425
pubmed: 28940415
J Investig Allergol Clin Immunol. 2012;22(3):188-92
pubmed: 22697008
J Ethnopharmacol. 2012 Sep 28;143(2):656-63
pubmed: 22885071
Am J Rhinol Allergy. 2016 May;30(3):53-7
pubmed: 27216335
J Inflamm (Lond). 2017 Jan 13;14:1
pubmed: 28100959
Eur J Pharmacol. 2015 May 5;754:153-61
pubmed: 25724787
Fitoterapia. 2014 Jul;96:131-7
pubmed: 24785965
Mediators Inflamm. 2011;2011:485402
pubmed: 21772663
Rhinology. 2016 Sep;54(3):266-72
pubmed: 27016898